Adrie C. Laan

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Clinical Cancer Research · 2008 · 208 citations

Medicine, Molecular Genetics, Oncology +17

Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1)

Jan Hendrik Hooijberg, Gerrit Jansen, Yehuda G. Assaraf et al. · Biochemical Pharmacology · 2004 · 45 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

Marcel N.A. Bijman, Cristian A. Hermelink, Maria P.A. van Berkel et al. · Biochemical Pharmacology · 2007 · 37 citations

Medicine, Oncology, Pharmacology +11

Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines

Olaf H. Temmink, Michiel de Bruin, Annelies W. Turksma et al. · The International Journal of Biochemistry & Cell Biology · 2006 · 33 citations

Medicine, Molecular Biology, Oncology +15

Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells

C Ceresa, Elisa Giovannetti, Jens Voortman et al. · Molecular Cancer Therapeutics · 2009 · 18 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15